本页面由Tiger Trade Technology Pte. Ltd.提供服务

Iovance Biotherapeutics, Inc.

4.11
+0.410011.08%
盘后4.06-0.0499-1.21%19:59 EDT
成交量:2,310.11万
成交额:9,381.26万
市值:18.35亿
市盈率:-4.43
高:4.20
开:3.70
低:3.69
收:3.70
52周最高:5.63
52周最低:1.66
股本:4.47亿
流通股本:3.88亿
量比:2.50
换手率:5.95%
股息:- -
股息率:- -
每股收益(TTM):-0.9281
每股收益(LYR):-1.0941
净资产收益率:-47.51%
总资产收益率:-23.65%
市净率:2.54
市盈率(LYR):-3.76

数据加载中...

2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/03

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]